These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 36409503)
1. Mediating Effects of Technology-Based Therapy on the Relationship Between Socioeconomic Status and Glycemic Management in Pediatric Type 1 Diabetes. Stanley JR; Clarke ABM; Shulman R; Mahmud FH Diabetes Technol Ther; 2023 Mar; 25(3):186-193. PubMed ID: 36409503 [No Abstract] [Full Text] [Related]
2. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis. Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z Front Public Health; 2022; 10():990281. PubMed ID: 36091534 [TBL] [Abstract][Full Text] [Related]
3. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion. Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275 [TBL] [Abstract][Full Text] [Related]
4. Time In Range in Children with Type 1 Diabetes Using Treatment Strategies Based on Nonautomated Insulin Delivery Systems in the Real World. Cherubini V; Bonfanti R; Casertano A; De Nitto E; Iannilli A; Lombardo F; Maltoni G; Marigliano M; Bassi M; Minuto N; Mozzillo E; Rabbone I; Rapini N; Rigamonti A; Salzano G; Scaramuzza A; Schiaffini R; Tinti D; Toni S; Zagaroli L; Zucchini S; Maffeis C; Gesuita R Diabetes Technol Ther; 2020 Jul; 22(7):509-515. PubMed ID: 32073311 [No Abstract] [Full Text] [Related]
5. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration. Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887 [TBL] [Abstract][Full Text] [Related]
6. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades? Citro F; Bianchi C; Nicolì F; Aragona M; Marchetti P; Di Cianni G; Bertolotto A Diabetes Res Clin Pract; 2023 Nov; 205():110979. PubMed ID: 37890701 [TBL] [Abstract][Full Text] [Related]
7. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study. Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663 [TBL] [Abstract][Full Text] [Related]
8. Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization. Parkin CG; Graham C; Smolskis J J Diabetes Sci Technol; 2017 May; 11(3):522-528. PubMed ID: 28745091 [TBL] [Abstract][Full Text] [Related]
9. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland. Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533 [TBL] [Abstract][Full Text] [Related]
10. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study. Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056 [No Abstract] [Full Text] [Related]
11. Technology use and clinical outcomes in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes. Baboun D; Solano N; Del Toro V; Alvarez-Salvat R; Granados A; Carrillo-Iregui A J Pediatr Endocrinol Metab; 2023 Dec; 36(12):1128-1132. PubMed ID: 37852007 [TBL] [Abstract][Full Text] [Related]
12. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827 [TBL] [Abstract][Full Text] [Related]
13. Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes. Yamada E; Nakajima Y; Horiguchi K; Okada S; Yamada M Endocr J; 2023 Dec; 70(12):1187-1193. PubMed ID: 37766568 [TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524 [TBL] [Abstract][Full Text] [Related]
15. Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes. Sawyer A; Sobczak M; Forlenza GP; Alonso GT Diabetes Technol Ther; 2022 Jun; 24(6):409-415. PubMed ID: 35099306 [No Abstract] [Full Text] [Related]
16. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures. Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892 [TBL] [Abstract][Full Text] [Related]
17. Temporal Trends for Diabetes Management and Glycemic Control Between 2010 and 2019 in Korean Children and Adolescents with Type 1 Diabetes. Choe J; Won SH; Choe Y; Park SH; Lee YJ; Lee J; Lee YA; Lim HH; Yoo JH; Lee SY; Kim EY; Shin CH; Kim JH Diabetes Technol Ther; 2022 Mar; 24(3):201-211. PubMed ID: 34704794 [No Abstract] [Full Text] [Related]
18. The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial. Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P J Diabetes Sci Technol; 2024 May; 18(3):660-666. PubMed ID: 36172693 [TBL] [Abstract][Full Text] [Related]
19. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660 [TBL] [Abstract][Full Text] [Related]
20. Glycemic Control by Treatment Modalities: National Registry-Based Population Data in Children and Adolescents with Type 1 Diabetes. Šumnik Z; Pavlíková M; Neuman V; Petruželková L; Konečná P; Venháčová P; Škvor J; Pomahačová R; Neumann D; Vosáhlo J; Strnadel J; Kocourková K; Obermannová B; Šantová A; Plachý L; Průhová S; Cinek O; Horm Res Paediatr; 2024; 97(1):70-79. PubMed ID: 37100041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]